lobbying_activities: 2685437

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2685437	95224de7-9e73-42f0-a943-b64c181e9733	Q3	CENTER FOR INDIVIDUAL FREEDOM	63952	CENTER FOR INDIVIDUAL FREEDOM	2021	third_quarter	CPT	S. 1425 - Stop STALLING Act S. 1428 - Preserve Access to Affordable Generics and Biosimilars Act S. 1435 -Affordable Prescriptions for Patients Act Correspondence with United States Senate in opposition to S. 1425 (the Stop STALLING Act); S. 1428 (the Preserve Access to Affordable Generics and Biosimilars Act); and S. 1435 (the Affordable Prescriptions for Patients Act); research relating thereto.	HOUSE OF REPRESENTATIVES,SENATE		10000	0	0	2021-10-18T14:36:13.433000-04:00